Mercator Medical S.A. (WSE:MRC)
Poland · Delayed Price · Currency is PLN 51.20
-0.70 (-1.35%)
Jul 22, 2026, 1:12 PM CET
Mercator Medical Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 145.64 | 542.49 | 469.06 | 542.51 | 1,727 | 1,834 | |
Revenue Growth (YoY) | -44.49% | 15.65% | -13.54% | -68.59% | -5.82% | 239.84% |
Cost of Revenue | 364.68 | 341.77 | 379.39 | 371.37 | 1,196 | 766.33 |
Gross Profit | -219.04 | 200.72 | 89.67 | 171.14 | 530.88 | 1,068 |
Depreciation & Amortization Expenses | 22.45 | 23.31 | 22.12 | 25.67 | 19.31 | 18.52 |
Other Operating Expenses | -1.37 | -60.44 | -3.18 | 91.45 | 48.14 | 1.71 |
Total Operating Expenses | 21.08 | -37.13 | 18.94 | 117.12 | 67.45 | 20.22 |
Operating Income | -240.12 | 237.85 | 70.73 | 54.03 | 463.43 | 1,048 |
Interest Income | 10.63 | 25.11 | 84.42 | 17.95 | 22.39 | 0.93 |
Interest Expense | -0.67 | -14.35 | -1.1 | -22.95 | -8.6 | -7.98 |
Total Non-Operating Income (Expense) | 9.96 | 10.76 | 83.32 | -5 | 13.79 | -7.06 |
Pretax Income | 10.24 | 41.86 | -3.79 | -186.22 | 477.23 | 1,041 |
Provision for Income Taxes | 2.09 | -7.97 | 19.04 | 4.57 | 32.37 | 105 |
Net Income | 8.15 | 49.83 | -22.84 | -190.79 | 444.85 | 935.57 |
Minority Interest in Earnings | -0.43 | -1.22 | -3.16 | -1.16 | -2.01 | 5.38 |
Net Income to Common | 8.58 | 51.05 | -19.68 | -189.62 | 446.87 | 930.19 |
Net Income Growth | -86.46% | - | - | - | -51.96% | - |
Shares Outstanding (Basic) | 9 | 9 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 9 | 9 | 10 | 10 | 10 | 11 |
Shares Change (YoY) | -1.62% | -2.02% | -1.91% | -3.47% | -3.88% | -0.55% |
EPS (Basic) | 1.31 | 5.31 | -2.38 | -19.53 | 44.15 | 89.18 |
EPS (Diluted) | 1.31 | 5.31 | -2.38 | -19.53 | 44.15 | 88.84 |
EPS Growth | -82.06% | - | - | - | -50.30% | - |
Free Cash Flow | - | -90.78 | -39.15 | -68.86 | 326.25 | 696.97 |
Free Cash Flow Growth | - | - | - | - | -53.19% | 2931.90% |
Free Cash Flow Per Share | - | -9.67 | -4.09 | -7.05 | 32.23 | 66.19 |
Dividends Per Share | 0.670 | 1.610 | - | - | - | - |
Dividend Growth | -58.38% | - | - | - | - | - |
Gross Margin | -150.39% | 37.00% | 19.12% | 31.55% | 30.73% | 58.22% |
Operating Margin | -164.87% | 43.85% | 15.08% | 9.96% | 26.83% | 57.12% |
Profit Margin | 5.59% | 9.19% | -4.87% | -35.17% | 25.75% | 51.01% |
FCF Margin | - | -16.73% | -8.35% | -12.69% | 18.89% | 38.00% |
EBITDA | -240.12 | 261.16 | 92.85 | 79.7 | 482.74 | 1,066 |
EBITDA Margin | -164.87% | 48.14% | 19.80% | 14.69% | 27.95% | 58.13% |
EBIT | -240.12 | 237.85 | 70.73 | 54.03 | 463.43 | 1,048 |
EBIT Margin | -164.87% | 43.85% | 15.08% | 9.96% | 26.83% | 57.12% |
Effective Tax Rate | 20.41% | -19.03% | -502.21% | -2.45% | 6.78% | 10.09% |